IRIS
FURFARO, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.688
AS - Asia 3.290
NA - Nord America 2.038
SA - Sud America 764
AF - Africa 105
OC - Oceania 8
Totale 9.893
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.270
US - Stati Uniti d'America 1.898
SG - Singapore 1.199
CN - Cina 847
BR - Brasile 629
HK - Hong Kong 534
IT - Italia 494
VN - Vietnam 349
FR - Francia 210
DE - Germania 152
SE - Svezia 126
GB - Regno Unito 112
NL - Olanda 72
CA - Canada 69
FI - Finlandia 67
IN - India 65
AR - Argentina 54
MX - Messico 54
PL - Polonia 48
BD - Bangladesh 44
JP - Giappone 42
ZA - Sudafrica 35
ID - Indonesia 31
IQ - Iraq 31
AT - Austria 30
EG - Egitto 29
ES - Italia 28
TR - Turchia 28
EC - Ecuador 26
UA - Ucraina 16
CO - Colombia 15
PK - Pakistan 14
SA - Arabia Saudita 12
CL - Cile 11
JO - Giordania 11
PT - Portogallo 11
PY - Paraguay 11
MA - Marocco 10
MY - Malesia 10
UZ - Uzbekistan 10
TN - Tunisia 9
LU - Lussemburgo 8
AU - Australia 7
IR - Iran 6
NP - Nepal 6
OM - Oman 6
PE - Perù 6
PH - Filippine 6
TW - Taiwan 6
VE - Venezuela 6
AZ - Azerbaigian 5
DZ - Algeria 5
LT - Lituania 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BE - Belgio 4
GR - Grecia 4
IE - Irlanda 4
IL - Israele 4
KE - Kenya 4
LB - Libano 4
BG - Bulgaria 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
KW - Kuwait 3
KY - Cayman, isole 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
CR - Costa Rica 2
GY - Guiana 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
SY - Repubblica araba siriana 2
TG - Togo 2
TH - Thailandia 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 9.887
Salva come PNG Salva come JPEG
Città #
Singapore 626
Hong Kong 524
Moscow 477
Ashburn 338
San Jose 288
Dallas 275
Hefei 178
Beijing 169
Lauterbourg 155
Ho Chi Minh City 142
Milan 100
New York 93
Los Angeles 84
Hanoi 70
Shanghai 68
Munich 67
Lawrence 58
Princeton 58
São Paulo 55
Council Bluffs 47
Orem 42
Helsinki 38
Warsaw 37
Montreal 30
Santa Clara 30
Frankfurt am Main 27
Tokyo 25
Manchester 24
Rome 24
Chicago 23
Johannesburg 23
Poplar 23
Denver 22
London 22
Chennai 21
Mexico City 21
Stockholm 21
Brooklyn 19
Phoenix 19
Nuremberg 17
Baghdad 16
Da Nang 15
Rio de Janeiro 15
Vienna 15
Atlanta 14
Curitiba 14
Turku 13
Amsterdam 12
Boston 12
Campinas 12
Lappeenranta 12
Toronto 12
Ankara 11
Belo Horizonte 11
Brasília 11
Charlotte 11
Naples 11
Amman 10
Dhaka 10
Florence 10
Porto Alegre 10
Tashkent 10
Houston 9
Mumbai 9
Querétaro 9
Quito 9
Slough 9
Boardman 8
Brescia 8
Esch-sur-Alzette 8
Falkenstein 8
Guayaquil 8
Haiphong 8
Hyderabad 8
Ninh Bình 8
Seattle 8
Cairo 7
Cape Town 7
Guangzhou 7
Hải Dương 7
Istanbul 7
Riyadh 7
Salvador 7
Sorocaba 7
Wuhan 7
Bari 6
Biên Hòa 6
Bologna 6
Erbil 6
Lahore 6
Niigata 6
Padova 6
Ribeirão Preto 6
Rosetta 6
Shenzhen 6
Thái Bình 6
Turin 6
Washington 6
Baku 5
Bexley 5
Totale 4.915
Salva come PNG Salva come JPEG
Nome #
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study 263
Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases 195
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches 134
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 118
Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment 117
Endoscopic Treatment Approaches for Inflammatory Bowel Diseases: Old Friends and New Weapons 115
Advancing Colorectal Cancer Prevention in Inflammatory Bowel Disease (IBD): Challenges and Innovations in Endoscopic Surveillance 108
Unlocking hope: The future of ustekinumab biosimilars in Crohn's disease treatment 105
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis 101
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities 101
Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease 95
Ulcerative colitis : current pharmacotherapy and future directions 94
Ulcerative colitis: Impact of early disease clearance on long-term outcomes - A multicenter cohort study 93
Inflammatory Bowel Disease and Colorectal Cancer 93
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 92
The Role of IL-23 Inhibitors in Crohn’s Disease 91
Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial 88
Accuracy of Information given by ChatGPT for patients with Inflammatory Bowel Disease in relation to ECCO Guidelines 88
Role of Probiotics in the Management of Patients with Ulcerative Colitis and Pouchitis 87
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 87
Multiple Ileal and Colonic Stenoses: Is It Always Crohn’s Disease? 86
P139 The learning curve of intestinal ultrasonography in assessing inflammatory bowel disease : preliminary results 85
Targeting mucosal healing in Crohn’s disease: efficacy of novel pathways and therapeutic targets 85
Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis 84
Bowel ultrasound in inflammatory bowel disease: How far in the grayscale? 82
Gastrointestinal Ultrasound in Infectious Diseases: A Comprehensive Review 82
New Technologies in Digestive Endoscopy for Ulcerative Colitis Patients 82
Leaving behind the Mucosa: Advances and Future Directions of Intestinal Ultrasound in Ulcerative Colitis 80
Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors 79
Neutrophil-only Histological Assessment of Ulcerative Colitis Correlates with Endoscopic Activity and Predicts Long-Term Outcomes in a Multicentre Study 79
Small Bowel Cancer in Crohn’s Disease 78
The Role of Vitamin D in Inflammatory Bowel Diseases: From Deficiency to Targeted Therapeutics and Precise Nutrition Strategies 78
Advanced endoscopic techniques in the assessment of inflammatory bowel disease: new technology, new era 77
Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases 76
The Role of Fecal Microbiota Transplantation in IBD 75
Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease 75
Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality? 74
y ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE 74
Epidemiological features and disease-related concerns of a large cohort of Italian patients with active Crohn's disease 73
Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future 73
The role of filgotinib in ulcerative colitis and Crohn's disease 73
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study 73
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 73
Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art 70
The Management of Postoperative Recurrence in Crohn’s Disease 70
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience 69
Raising the bar in ulcerative colitis management 68
Biosimilars of adalimumab: the upcoming challenge in IBD 68
Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question 67
Risk factors for depression and anxiety in Crohn's disease 67
Bowel ultrasound is accurate in assessing disease activity in ulcerative colitis 67
Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that? 67
An Unusual Case of Cardiac Involvement in Crohn's Disease 67
Abdominal pain after minor trauma in a patient with Crohn's disease 67
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials 67
Transforming Gastrointestinal Diagnosis with Molecular Endoscopy: Challenges and Opportunities 66
Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn's disease: a prospective cohort study 65
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD 65
Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures 64
Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience 63
ASSESSMENT OF THE DISEASE EXTENSION IN CHILDREN AND ADOLESCENTS WITH IBD: COMPARISON OF BOWEL ULTRASOUND AND MAGNETIC RESONANCE ENTEROGRAPHY 62
Accuracy of a New Fujiifilm Blue Light Prototype in Predicting the Histology of Subcentimetric Polyps 61
STIMULATION OF CYP450-MEDIATED omega-3 DOCOSAHEXAENOIC ACID (DHA) METABOLISM VIA MFSD2A AS A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE 61
Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease 60
Psychological Functioning of Patients With Inflammatory Bowel Disease 59
Cross-Sectional Imaging Instead of Colonoscopy in Inflammatory Bowel Diseases: Lights and Shadows 59
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology 59
Carcinomas in inflammatory bowel disease: a narrative review on diagnostic imaging techniques 58
JAK inhibitors: Novel developments in management of ulcerative colitis 58
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 58
BOWEL ULTRASOUND IS ACCURATE IN ASSESSING DISEASE ACTIVITY IN ULCERATIVE COLITIS 57
Can IL-23 be a good target for ulcerative colitis? 57
Clostridioides difficile infection in hospital and community settings: summary document of a multidisciplinary group 56
Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials 56
SWITCHING FROM INFLIXIMAB ORIGINATOR TO CT-P13 IS NOT RELATED TO INCREASED IMMUNOGENICITY IN IBD PATIENTS: A PROSPECTIVE CASE-CONTROL STUDY 56
Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts 56
Psychological factors and quality of life in inflammatory bowel diseases patients: the Psycho study 55
Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients 55
ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease 54
Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study 54
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study 53
COMPARATIVE ACCURACY OF US VERSUS MRI AND COLONOSCOPY IN ASSESSING DISEASE ACTIVITY AND COMPLICATIONS AND INFLUENCING THE DECISION-MAKING PROCESS IN CROHN'S DISEASE 53
Comparison of two methods for the in-vivo diagnosis of Helicobacter pylori infection using a tablet of C-13-urea 52
Point-of-Care Ultrasound in Inflammatory Bowel Disease 52
JAK inhibitors in crohn’s disease: ready to go? 52
Improving quality of care in endoscopy of inflammatory bowel disease: can we do better? 50
Early Intestinal Ultrasound Predicts Long-Term Endoscopic Response to Biologics in Ulcerative Colitis 49
Infliximab discontinuation is associated with a higher risk for relapse in patients with ulcerative colitis in remission: a multinational collaborative retrospective study 49
Validation of the Red Flags Index for Early Diagnosis of Crohn's Disease: A Prospective Observational IG-IBD Study Among General Practitioners 49
Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease 49
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration 49
Disease patterns in late-onset ulcerative colitis: Results from the " IG-IBD ""AGED study""" 48
Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease 48
Prevention of Postoperative Recurrence in CD: Tailoring Treatment to Patient Profile 48
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 47
The safety of biological pharmacotherapy for the treatment of ulcerative colitis 46
Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block 46
Infliximab Discontinuation Is Associated With a Higher Risk for Relapse in Patients With Ulcerative Colitis in Remission: A Multinational Collaborative Retrospective Study 46
Milan Ultrasound Criteria are accurate in assessing disease activity in ulcerative colitis: External validation 46
Modulation of sphingosine-1-phosphate in ulcerative colitis 46
Totale 7.327
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202292 0 0 0 73 1 5 0 1 0 2 5 5
2022/2023252 149 36 9 2 1 25 10 9 8 2 0 1
2023/202461 1 3 2 0 4 16 3 6 0 0 2 24
2024/20251.881 106 8 13 3 1 56 134 295 357 495 147 266
2025/20267.842 663 597 505 1.065 765 320 751 676 2.170 330 0 0
Totale 10.128